Prevention of radiation-induced oral mucositis after adenoviral vector–mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands
C Zheng, AP Cotrim, AN Sunshine, T Sugito, L Liu… - Clinical cancer …, 2009 - AACR
Purpose: The study aims to evaluate if human keratinocyte growth factor (hKGF), secreted
after transduction of murine salivary glands with adenoviral vectors, can prevent oral …
after transduction of murine salivary glands with adenoviral vectors, can prevent oral …
Aspectos clínicos, biológicos, histopatológicos e tratamentos propostos para a mucosite oral induzida por radioterapia: revisão da literatura
A mucosite oral é um dos principais efeitos colaterais agudos induzidos pelo tratamento
radioterápico em cabeça e pescoço, surgindo a partir da segunda semana de tratamento e …
radioterápico em cabeça e pescoço, surgindo a partir da segunda semana de tratamento e …
Allopurinol mouth rinse for prophylaxis of fluorouracil‐induced mucositis
Y Panahi, S Ala, M Saeedi… - European Journal of …, 2010 - Wiley Online Library
PANAHI Y., ALA S., SAEEDI M., OKHOVATIAN A., BAZZAZ N. & NAGHIZADEH MM (2010)
European Journal of Cancer Care19, 308–312 Allopurinol mouth rinse for prophylaxis of …
European Journal of Cancer Care19, 308–312 Allopurinol mouth rinse for prophylaxis of …
Prevenção da xerostomia e da mucosite oral induzidas por radioterapia com uso do laser de baixa potência
CO Lopes, JRI Mas, RA Zângaro - Radiologia Brasileira, 2006 - SciELO Brasil
OBJETIVO: Verificar se o uso do laser de InGaAlP com comprimento de onda de 685 nm
pode reduzir a incidência de xerostomia, gravidade da mucosite oral e da dor associada à …
pode reduzir a incidência de xerostomia, gravidade da mucosite oral e da dor associada à …
[图书][B] Melatonin in the Promotion of Health
RR Watson - 2011 - books.google.com
Melatonin is a powerful hormone and antioxidant with numerous effects on the metabolism
and the health of humans. Available as a dietary supplement in the United States since …
and the health of humans. Available as a dietary supplement in the United States since …
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
JE Jacob, DP Nowotnik, CM Baud - US Patent 7,547,433, 2009 - Google Patents
Stable, viscous, mucoadhesive aqueous compositions Which are useful for the prevention
and treatment of ulcerative, in? ammatory, and/or erosive disorders of mucous mem branes …
and treatment of ulcerative, in? ammatory, and/or erosive disorders of mucous mem branes …
Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation
W Dörr, S Reichel, K Spekl - Radiotherapy and Oncology, 2005 - Elsevier
BACKGROUND AND PURPOSE: Aim of this study was to assess the impact of the
administration protocol of palifermin on amelioration of oral mucositis after fractionated …
administration protocol of palifermin on amelioration of oral mucositis after fractionated …
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
JE Jacob, DP Nowotnik, CM Baud - US Patent 7,544,348, 2009 - Google Patents
US7544348B2 - Liquid formulations for the prevention and treatment of mucosal diseases
and disorders - Google Patents US7544348B2 - Liquid formulations for the prevention and …
and disorders - Google Patents US7544348B2 - Liquid formulations for the prevention and …
Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation
G Ara, BA Watkins, H Zhong… - … journal of radiation …, 2008 - Taylor & Francis
Purpose: Velafermin (recombinant human fibroblast growth factor-20, rhFGF-20) has been
shown to reduce the severity and duration of mucositis in preclinical acute (single dose) …
shown to reduce the severity and duration of mucositis in preclinical acute (single dose) …
Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF
W Dörr, K Heider, K Spekl - International journal of radiation …, 2005 - Taylor & Francis
Purpose: The aim of the present study was to determine the dose effect of palifermin
(recombinant human keratinocyte growth factor, rHuKGF) for reduction of the response of …
(recombinant human keratinocyte growth factor, rHuKGF) for reduction of the response of …